当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析 - 现金流量表

晨光生物

(300138)

  

流通市值:43.66亿  总市值:52.95亿
流通股本:3.98亿   总股本:4.83亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,817,655,715.387,591,161,036.985,058,450,186.963,352,339,818.76
收到的税费返还67,535,729.33102,921,119.799,666,812.7299,609,472.92
收到其他与经营活动有关的现金33,405,513.7184,659,672.63158,577,895.5152,672,744.27
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,918,596,958.417,878,741,829.315,316,694,895.193,504,622,035.95
购买商品、接受劳务支付的现金1,233,677,978.337,568,768,067.63,296,300,133.062,202,749,271.81
支付给职工以及为职工支付的现金64,956,734.38252,264,199.61189,378,670.95127,419,162.79
支付的各项税费29,982,725.2110,179,820.2890,508,447.6766,336,818.33
支付其他与经营活动有关的现金59,535,112.53170,344,701.79137,321,034.4175,032,754.12
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,388,152,550.448,101,556,789.283,713,508,286.092,471,538,007.05
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额530,444,407.97-222,814,959.971,603,186,609.11,033,084,028.9
二、投资活动产生的现金流量:
收回投资收到的现金1,084,403,155.61,021,788,639.791,155,980,563.47888,291,807.47
取得投资收益收到的现金9,683,526.8238,572,939.8310,788,235.6413,232,282.22
处置固定资产、无形资产和其他长期资产收回的现金净额4,402,32016,655.5394,149.5394,149.53
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,098,489,002.421,060,378,235.151,166,862,948.64901,618,239.22
购建固定资产、无形资产和其他长期资产支付的现金25,054,833.31149,537,086.88149,980,402.6483,394,374.36
投资支付的现金2,550,042,486.951,337,369,151.29801,677,762.46548,175,676.63
支付其他与投资活动有关的现金-14,426,983.15--
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,575,097,320.261,501,333,221.32951,658,165.1631,570,050.99
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,476,608,317.84-440,954,986.17215,204,783.54270,048,188.23
三、筹资活动产生的现金流量:
取得借款收到的现金1,505,278,154.265,783,439,209.463,448,038,020.22,887,838,020.2
收到其他与筹资活动有关的现金--220,000,000-
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,505,278,154.265,783,439,209.463,668,038,020.22,887,838,020.2
偿还债务支付的现金311,000,0005,087,427,9593,643,082,9692,578,917,000
分配股利、利润或偿付利息支付的现金24,287,014.63174,848,426.65152,004,899.95129,278,342.95
其中:子公司支付给少数股东的股利、利润-793,517.8793,517.8793,517.8
支付其他与筹资活动有关的现金-417,362,455.29444,515,155.91321,849,396.36
筹资活动现金流出平衡项目0000
筹资活动现金流出小计335,287,014.635,679,638,840.944,239,603,024.863,030,044,739.31
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额1,169,991,139.63103,800,368.52-571,565,004.66-142,206,719.11
四、汇率变动对现金及现金等价物的影响-2,338,013.84-10,493,145.08-6,716,726.56-4,916,168.61
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额221,489,215.92-570,462,722.71,240,109,661.421,156,009,329.41
加:期初现金及现金等价物余额514,802,240.021,085,264,962.721,085,264,962.721,085,264,962.72
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额736,291,455.94514,802,240.022,325,374,624.142,241,274,292.13
补充资料:
净利润-77,957,113.49-93,790,702.64
资产减值准备-95,164,207.13-2,369,527.74
固定资产和投资性房地产折旧-157,696,415.82-78,680,188.34
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-157,696,415.82-78,680,188.34
无形资产摊销-8,969,905.84-7,856,874.98
长期待摊费用摊销-200,000.04-100,000.02
处置固定资产、无形资产和其他长期资产的损失--4,887,839.58--
固定资产报废损失-457,881.85-202,988.68
公允价值变动损失-5,111,280.46-6,447,474.73
财务费用-114,417,669.76-65,144,695.63
投资损失--17,787,444.36--15,988,000.75
递延所得税--14,036,732.47-2,483,724.93
其中:递延所得税资产减少--12,171,171.29-2,623,242.89
递延所得税负债增加--1,865,561.18--139,517.96
存货的减少--670,569,278.44-758,240,342.27
经营性应收项目的减少-62,071,449.5-130,098,055.13
经营性应付项目的增加--41,673,355.69--153,011,337.12
其他---55,826,094.72
现金的期末余额-514,802,240.02-1,991,274,292.13
减:现金的期初余额-875,264,962.72-875,264,962.72
加:现金等价物的期末余额---250,000,000
减:现金等价物的期初余额-210,000,000-210,000,000
公告日期2025-04-262025-04-082024-10-262024-08-27
审计意见(境内)标准无保留意见
TOP↑